Methods of using human mesenchymal stem cells to effect cellular and humoral immunity

NZ794292BActive Publication Date: 2026-09-29LONGEVERON INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: NZ794292
Authority / Receiving Office: NZ · NZ
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2016-11-11
Filing Date: 2017-11-10
Publication Date: 2026-09-29
Estimated Expiration: 2037-11-10

Application Information

Patent Timeline

11 Nov 2016

Priority

10 Nov 2017

Application

NZ794292

29 Sep 2026

Publication

NZ794292B

IPC: A61K35/28; A61P9/00; A61P39/00; G01N33/15

Inventors: HARE, JOSHUA M.; LANDIN, ANA MARIE

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Smart Images

Figure 00000040_0000
Figure 00000042_0000
Figure 00000043_0000

Patent Text Reader

Abstract

The present invention provides a method of treating subjects with non-ischemic dilated cardiomyopathy by administering a therapeutically effective amount of an isolated population of allogeneic human mesenchymal stem cells. The present invention also provides a method of treating subjects with symptoms of aging frailty by administering a therapeutically effective amount of an isolated population of allogeneic human mesenchymal stem cells.

Need to check novelty before this filing date? Find Prior Art